High Grade Astrocytic Tumor — Trials

High Grade Astrocytic Tumor — Trials · CancerIndex

Clinical trials

Registered studies

1,778 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 495
Recruiting: 263
Ph III recruiting: 15
Growth YoY: +41.8%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (283)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05664464	Glutamate Inhibitors in Glioblastoma(GLUGLIO)	recruiting	Phase 1 / Phase 2	120	University of ZurichOTHER	1	May 10, 2024	clinicaltrials
NCT05577091	Tris-CAR-T Cell Therapy for Recurrent Glioblastoma	recruiting	Phase 1	10	Beijing Tiantan HospitalOTHER	1	Apr 12, 2024	clinicaltrials
NCT04443010